DE60028374T2 - Verfahren und apparatur zum präsentieren von daten von thrombose- und haemostaseassays - Google Patents
Verfahren und apparatur zum präsentieren von daten von thrombose- und haemostaseassays Download PDFInfo
- Publication number
- DE60028374T2 DE60028374T2 DE60028374T DE60028374T DE60028374T2 DE 60028374 T2 DE60028374 T2 DE 60028374T2 DE 60028374 T DE60028374 T DE 60028374T DE 60028374 T DE60028374 T DE 60028374T DE 60028374 T2 DE60028374 T2 DE 60028374T2
- Authority
- DE
- Germany
- Prior art keywords
- time
- sample
- profile
- data
- samples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract description 12
- 208000007536 Thrombosis Diseases 0.000 title abstract description 8
- 238000003556 assay Methods 0.000 title abstract description 6
- 239000000523 sample Substances 0.000 description 72
- 102000008946 Fibrinogen Human genes 0.000 description 28
- 108010049003 Fibrinogen Proteins 0.000 description 28
- 229940012952 fibrinogen Drugs 0.000 description 28
- 238000005345 coagulation Methods 0.000 description 21
- 238000005259 measurement Methods 0.000 description 20
- 230000015271 coagulation Effects 0.000 description 19
- 230000003287 optical effect Effects 0.000 description 19
- 230000036962 time dependent Effects 0.000 description 19
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 18
- 229960002897 heparin Drugs 0.000 description 18
- 229920000669 heparin Polymers 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 239000003146 anticoagulant agent Substances 0.000 description 9
- 206010053567 Coagulopathies Diseases 0.000 description 8
- 230000035602 clotting Effects 0.000 description 8
- DWHCYDWXLJOFFO-UHFFFAOYSA-N 4-(5-phenylthiophen-2-yl)aniline Chemical compound C1=CC(N)=CC=C1C1=CC=C(C=2C=CC=CC=2)S1 DWHCYDWXLJOFFO-UHFFFAOYSA-N 0.000 description 7
- 230000002159 abnormal effect Effects 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 210000002381 plasma Anatomy 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 102100026735 Coagulation factor VIII Human genes 0.000 description 4
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 210000004205 output neuron Anatomy 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 3
- 238000000149 argon plasma sintering Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 241001136792 Alle Species 0.000 description 2
- 108010076282 Factor IX Proteins 0.000 description 2
- 108010014172 Factor V Proteins 0.000 description 2
- 108010023321 Factor VII Proteins 0.000 description 2
- 108010054218 Factor VIII Proteins 0.000 description 2
- 108010014173 Factor X Proteins 0.000 description 2
- 108010074864 Factor XI Proteins 0.000 description 2
- 108010080865 Factor XII Proteins 0.000 description 2
- 229940096437 Protein S Drugs 0.000 description 2
- 102000029301 Protein S Human genes 0.000 description 2
- 108010066124 Protein S Proteins 0.000 description 2
- 108010094028 Prothrombin Proteins 0.000 description 2
- 238000013528 artificial neural network Methods 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 229940127216 oral anticoagulant drug Drugs 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 101800004937 Protein C Proteins 0.000 description 1
- 102000017975 Protein C Human genes 0.000 description 1
- 101800001700 Saposin-D Proteins 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 229960000856 protein c Drugs 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000013179 statistical model Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/4905—Determining clotting time of blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/22—Haematology
- G01N2800/224—Haemostasis or coagulation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/22—Haematology
- G01N2800/226—Thrombotic disorders, i.e. thrombo-embolism irrespective of location/organ involved, e.g. renal vein thrombosis, venous thrombosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/38—Pediatrics
- G01N2800/385—Congenital anomalies
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Ecology (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US345080 | 1999-06-30 | ||
| US09/345,080 US6502040B2 (en) | 1997-12-31 | 1999-06-30 | Method for presenting thrombosis and hemostasis assay data |
| PCT/US2000/018310 WO2001001152A1 (en) | 1999-06-30 | 2000-06-30 | Method and apparatus for presenting thrombosis and hemostasis assay data |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60028374D1 DE60028374D1 (de) | 2006-07-06 |
| DE60028374T2 true DE60028374T2 (de) | 2007-06-06 |
Family
ID=23353417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60028374T Expired - Lifetime DE60028374T2 (de) | 1999-06-30 | 2000-06-30 | Verfahren und apparatur zum präsentieren von daten von thrombose- und haemostaseassays |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6502040B2 (https=) |
| EP (1) | EP1188060B1 (https=) |
| JP (1) | JP2003529046A (https=) |
| KR (1) | KR20020042539A (https=) |
| AT (1) | ATE328327T1 (https=) |
| AU (1) | AU768436B2 (https=) |
| CA (1) | CA2377528C (https=) |
| DE (1) | DE60028374T2 (https=) |
| ES (1) | ES2270850T3 (https=) |
| WO (1) | WO2001001152A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005520170A (ja) * | 2001-06-29 | 2005-07-07 | バイオメリュー・インコーポレイテッド | 患者における抗リン脂質抗体症候群の可能性の上昇を予測するための方法 |
| WO2003063929A1 (en) * | 2002-01-28 | 2003-08-07 | Debiotech S.A. | Peritoneal dialysis system |
| US9125989B2 (en) | 2003-01-23 | 2015-09-08 | Debiotech S.A. | Device for determining the characteristics of peritoneal membrane |
| ES1063877Y (es) | 2006-10-02 | 2007-03-16 | Lafuente Flo Rosa | Funda perfeccionada para cascos de motocicleta |
| JP5602027B2 (ja) * | 2008-02-14 | 2014-10-08 | オリオン ディアグノスティカ オサケ ユキチュア | 未来の性質を予測する方法 |
| US20110104725A1 (en) * | 2008-05-02 | 2011-05-05 | Advanced Liquid Logic, Inc. | Method of Effecting Coagulation in a Droplet |
| US20090298103A1 (en) * | 2008-05-20 | 2009-12-03 | The University Of Vermont And State Agriculture College | Predicting hemostatic risk; dependence on plasma composition |
| JP5982976B2 (ja) * | 2012-04-13 | 2016-08-31 | ソニー株式会社 | 血液凝固系解析装置、血液凝固系解析方法及びそのプログラム |
Family Cites Families (93)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3307392A (en) | 1964-05-04 | 1967-03-07 | Research Corp | Automatic prothrombin timer apparatus and method |
| US3458287A (en) | 1965-04-29 | 1969-07-29 | Medical Laboratory Automation | Method and means of determining endpoint times in blood clotting tests |
| US3658480A (en) | 1970-04-13 | 1972-04-25 | Bio Data Corp | Coagulation timing apparatus, and method |
| US4047890A (en) | 1973-11-01 | 1977-09-13 | Bio/Data Corporation | Method and apparatus for determining deficiencies in enzymatic reactors particularly clotting factor levels in blood plasmas |
| SU590665A1 (ru) | 1976-02-11 | 1978-01-30 | Новосибирский государственный медицинский институт | Способ исследовани процесса свертывани крови |
| US4040788A (en) | 1976-04-05 | 1977-08-09 | Sanford L. Simons | Apparatus, instrumentation, and method for comparing samples |
| DE2635081C3 (de) | 1976-08-04 | 1980-08-07 | Bio/Data Corp., Willow Grove, Pa. (V.St.A.) | Verfahren und Vorrichtung zur Bestimmung von Blutplasma-Gerinnungsfaktorpegeln |
| FR2364453A1 (fr) | 1976-09-08 | 1978-04-07 | Lacombe Pierre | Dispositif electronique apportant un perfectionnement aux appareils destines a analyser la coagulation sanguine : prothrombinometre citrate-oxalate |
| US4199748A (en) | 1976-11-01 | 1980-04-22 | Rush-Presbyterian-St. Luke's Medical Center | Automated method and apparatus for classification of cells with application to the diagnosis of anemia |
| JPS5451893A (en) | 1977-09-30 | 1979-04-24 | Sankyo Co | Measuring of blood coagulating time |
| JPS5822703B2 (ja) | 1978-08-30 | 1983-05-10 | 三共株式会社 | 血液凝固測定方法 |
| US4289498A (en) | 1979-01-08 | 1981-09-15 | Ortho Diagnostics, Inc. | One-stage prothrombin assay and compositions useful therein |
| US4766083A (en) | 1982-04-04 | 1988-08-23 | Wako Pure Chemical Industries, Ltd. | Method for the photometric determination of biological agglutination |
| SU1076086A1 (ru) | 1982-12-28 | 1984-02-29 | Всесоюзный Научно-Исследовательский И Конструкторский Институт Медицинской Лабораторной Техники | Гемокоагулограф |
| EP0115459A3 (en) | 1983-01-26 | 1986-11-20 | University Of Medicine And Dentistry Of New Jersey | Hematological prediction of sepsis and other disease states |
| US4705756A (en) | 1983-01-26 | 1987-11-10 | University Of Medicine And Dentistry Of New Jersey | Method of determining the existence and/or the monitoring of a pathological condition in a mammal |
| JPS59203959A (ja) | 1983-05-04 | 1984-11-19 | Toa Medical Electronics Co Ltd | 血液凝固時間測定装置 |
| JPH0695095B2 (ja) | 1983-11-25 | 1994-11-24 | 株式会社島津製作所 | 全自動血液分析装置 |
| DE3502878A1 (de) | 1985-01-29 | 1986-07-31 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur bestimmung des fibrinolytischen zustands von plasma |
| JPS61272655A (ja) | 1985-05-28 | 1986-12-02 | Iryo Kogaku Kenkyusho:Kk | 血小板凝集能の定量的判定方法 |
| GB8516081D0 (en) | 1985-06-25 | 1985-07-31 | Ciba Geigy Ag | Assay & purification of amyloid components |
| US4902630A (en) | 1985-07-22 | 1990-02-20 | Abbott Laboratories | Fluorescence polarization immunoassy and reagents for measurement of c-reactive protein |
| ATE134880T1 (de) | 1988-04-04 | 1996-03-15 | Lawrence A Potempa | Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinen |
| US5593897A (en) | 1988-04-04 | 1997-01-14 | Northwestern University | Binding of immune complexes by modified forms of C-reactive protein |
| US4965725B1 (en) | 1988-04-08 | 1996-05-07 | Neuromedical Systems Inc | Neural network based automated cytological specimen classification system and method |
| US5156974A (en) | 1988-05-27 | 1992-10-20 | Biodata Corporation | Method for determining the fibrinogen level of a blood sample |
| US5003065A (en) | 1988-06-14 | 1991-03-26 | Carey Merritt | Compounds and process for measuring c-reactive protein |
| US5697369A (en) * | 1988-12-22 | 1997-12-16 | Biofield Corp. | Method and apparatus for disease, injury and bodily condition screening or sensing |
| US5055412A (en) | 1989-03-21 | 1991-10-08 | Proksch Gary J | Factor sensitive reagent for testing of blood coagulation containing ellagic acid and divalent metal ions and method of making the same |
| US5500345A (en) | 1989-04-25 | 1996-03-19 | Iatron Laboratories, Inc. | Hybridomas producing monoclonal antibodies specific for C-reactive protein and methods for detection of C-reactive protein |
| WO1991000872A1 (en) | 1989-06-27 | 1991-01-24 | Rush-Presbyterian-St. Luke's Medical Centre | Monoclonal antibodies to c-reactive protein |
| US5051357A (en) | 1989-07-14 | 1991-09-24 | Board Of Trustees Operating Michigan State University | Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor |
| WO1991001383A1 (en) | 1989-07-14 | 1991-02-07 | Michigan State University | Method for diagnosing blood clotting disorders |
| AU6067190A (en) | 1989-07-20 | 1991-02-22 | Analytical Control Systems, Inc. | Improved stable coagulation controls |
| SU1691741A1 (ru) | 1989-08-25 | 1991-11-15 | Донецкий государственный медицинский институт | Способ прогнозировани геморрагических осложнений при травматической болезни |
| US4998535A (en) | 1989-09-05 | 1991-03-12 | Univ. of Washington New England Medical Center Hospitals, Inc. | Thrombolysis predictive instrument |
| US5262303A (en) | 1989-10-13 | 1993-11-16 | Trustees Of Boston University | Ligand/anti-ligand assays for adherent proteins |
| IE904244A1 (en) | 1989-12-01 | 1991-06-05 | Akzo Nv | Direct fibrinogen assay |
| US5646046A (en) | 1989-12-01 | 1997-07-08 | Akzo Nobel N.V. | Method and instrument for automatically performing analysis relating to thrombosis and hemostasis |
| US5169786A (en) | 1989-12-19 | 1992-12-08 | Ortho Diagnostic Systems, Inc. | Method of determining levels of extrinsic and intrinsic clotting factors and protein c |
| EP0525035B1 (en) | 1990-04-17 | 1996-07-03 | Analytical Control Systems, Inc. | Coagulation assays and reagents |
| US5862304A (en) | 1990-05-21 | 1999-01-19 | Board Of Regents, The University Of Texas System | Method for predicting the future occurrence of clinically occult or non-existent medical conditions |
| US5218529A (en) | 1990-07-30 | 1993-06-08 | University Of Georgia Research Foundation, Inc. | Neural network system and methods for analysis of organic materials and structures using spectral data |
| JPH04254760A (ja) | 1991-01-30 | 1992-09-10 | Eiken Chem Co Ltd | 血清アミロイドａ標準物質、およびその設定方法 |
| US5221628A (en) | 1991-03-19 | 1993-06-22 | Northwestern University | Binding of aggregated immunoglobulin or immune complexes by serum amyloid P component |
| RU2012877C1 (ru) | 1991-04-01 | 1994-05-15 | Белорусский научно-исследовательский институт охраны материнства и детства | Способ прогнозирования синдрома дыхательных расстройств у недоношенных новорожденных |
| EP0525273B1 (en) | 1991-08-02 | 1996-10-16 | Grupo Grifols, S.A. | Process and apparatus for the determination of the coagulation time of blood and plasma |
| JPH0559415A (ja) * | 1991-09-02 | 1993-03-09 | Kobe Steel Ltd | 高炉炉熱変化推定装置 |
| WO1993007491A1 (en) | 1991-10-04 | 1993-04-15 | Board Of Regents Of The University Of Nebraska | A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins |
| US5716795A (en) | 1991-10-04 | 1998-02-10 | Matschiner; John T. | Thrombomodulin-based coagulometric assay of the protein C system |
| WO1993009438A1 (en) | 1991-11-04 | 1993-05-13 | Adeza Biomedical Corporation | Screening method for identifying women at increased risk for preterm delivery |
| JPH05180835A (ja) | 1991-12-27 | 1993-07-23 | S R L:Kk | ループスアンチコアグラントの測定方法 |
| US5318958A (en) | 1992-05-29 | 1994-06-07 | Queen's University At Kingston | Amyloid precursor protein |
| JP2934557B2 (ja) | 1992-07-10 | 1999-08-16 | 国際試薬株式会社 | 血液凝固時間測定方法とその装置 |
| JPH0636061A (ja) | 1992-07-21 | 1994-02-10 | Fujitsu Ltd | 階層型ニューラルネットワークの学習方式 |
| DE4224621C2 (de) * | 1992-07-25 | 1994-05-05 | Boehringer Mannheim Gmbh | Verfahren zur Analyse eines Bestandteils einer medizinischen Probe mittels eines automatischen Analysegerätes |
| US5388164A (en) | 1992-08-19 | 1995-02-07 | Olympus Optical Co., Ltd. | Method for judging particle agglutination patterns using neural networks |
| JP3224607B2 (ja) | 1992-09-11 | 2001-11-05 | 株式会社アズウェル | 血液凝固第ｘｉｉｉ因子活性測定方法および該測定用試薬キット |
| US5369484A (en) | 1992-11-09 | 1994-11-29 | Akzo N.V. | Multiple discrete analyzer test apparatus and method |
| US5358852A (en) | 1992-12-21 | 1994-10-25 | Eastman Kodak Company | Use of calcium in immunoassay for measurement of C-reactive protein |
| RU2070327C1 (ru) | 1992-12-25 | 1996-12-10 | Безруков Александр Васильевич | Устройство для измерения времени свертывания крови |
| US5344754A (en) | 1993-01-13 | 1994-09-06 | Avocet Medical, Inc. | Assay timed by electrical resistance change and test strip |
| JP2938302B2 (ja) | 1993-02-25 | 1999-08-23 | 国際試薬株式会社 | 血液凝固時間測定方法とその装置 |
| JPH06249857A (ja) | 1993-02-26 | 1994-09-09 | Hitachi Ltd | 自動分析装置 |
| RU2061953C1 (ru) | 1993-03-10 | 1996-06-10 | Тюменский государственный медицинский институт МЗ РФ | Способ количественного определения общей коагуляционной активности тромбоцитов |
| US5670329A (en) | 1993-05-28 | 1997-09-23 | Cardiovascular Diagnostics, Inc. | Method and analytical system for performing fibrinogen assays accurately, rapidly and simply using a rotating magnetic field |
| CA2168452A1 (en) | 1993-08-16 | 1995-02-23 | Timothy J. Fischer | Method and instrument for automatically performing analysis relating to thrombosis and hemostasis |
| US5526111A (en) | 1993-08-31 | 1996-06-11 | Boehringer Mannheim Corporation | Method and apparatus for calculating a coagulation characteristic of a sample of blood a blood fraction or a control |
| US5472852A (en) | 1993-09-15 | 1995-12-05 | Oklahoma Medical Research Foundation | Assay for detection of selective Protein C inhibition by patients |
| US5473732A (en) | 1993-11-02 | 1995-12-05 | Chang; Hou-Mei H. | Relational artificial intelligence system |
| US5553616A (en) | 1993-11-30 | 1996-09-10 | Florida Institute Of Technology | Determination of concentrations of biological substances using raman spectroscopy and artificial neural network discriminator |
| US5856114A (en) * | 1994-03-21 | 1999-01-05 | The University Of Vermont | Immunologic detection of factor VA fragments in hemorrhagic and thrombotic clinical settings |
| CA2165412A1 (en) | 1994-04-28 | 1995-10-29 | Barry John Woodhams | Calibrator for prothrombin time (pt) assays |
| WO1996006624A1 (en) | 1994-08-26 | 1996-03-07 | Immtech International, Inc. | A mutant protein and methods and materials for making and using it |
| US5504011A (en) | 1994-10-21 | 1996-04-02 | International Technidyne Corporation | Portable test apparatus and associated method of performing a blood coagulation test |
| SE9403833D0 (sv) | 1994-11-08 | 1994-11-08 | Global Hemostasis Inst Mgr Ab | Analysförfarande och kit |
| US5705395A (en) * | 1994-11-14 | 1998-01-06 | The Scripps Research Institute | Method for diagnosis of thrombotic disorders |
| US5567596A (en) | 1994-12-29 | 1996-10-22 | Research Foundation Of State University Of New York | Rapid assay of activators and inhibitors of clotting |
| DE69615339T2 (de) | 1995-01-10 | 2002-07-04 | Hemker, Hendrik Coenraad | Verfahren zum nachweis des endogenen thrombin-potentials und thrombin substrate zur verwendung in diesen verfahren |
| US5708591A (en) | 1995-02-14 | 1998-01-13 | Akzo Nobel N.V. | Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions |
| US6321164B1 (en) | 1995-06-07 | 2001-11-20 | Akzo Nobel N.V. | Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade |
| US5780255A (en) | 1995-06-09 | 1998-07-14 | Instrumentation Laboratory, S.P.A. | Protein C pathway screening test |
| ATE190728T1 (de) | 1995-07-21 | 2000-04-15 | Trinity College Dublin | Verfahren zur quantitativen bestimmung menschlichen akutphasen-serum-amyloid-a-proteins; rekombinantes protein; spezifischer antikörper |
| US5766869A (en) | 1995-11-30 | 1998-06-16 | Ahs Hospital Corp. | Factor V ratio blood test for susceptibility to thromboembolism |
| BR9702199A (pt) | 1996-03-22 | 1999-07-20 | Dade Int Inc | Combinação de dispositivo de teste e suporte de reagente |
| JPH1026621A (ja) | 1996-07-12 | 1998-01-27 | Dai Ichi Pure Chem Co Ltd | イムノアッセイ法 |
| US5684007A (en) | 1996-09-05 | 1997-11-04 | Otsuka Pharmaceutical Co., Ltd. | Methods for inhibiting cardiac fibroblast growth and cardiac fibrosis |
| JP3876022B2 (ja) | 1996-09-26 | 2007-01-31 | 生化学工業株式会社 | 血液凝固時間に影響を与える物質の定量方法 |
| WO2000007012A1 (en) | 1998-07-31 | 2000-02-10 | Carroll Wallace E | Method and apparatus for determining anticoagulant therapy factors |
| EP0841566A1 (en) | 1996-11-11 | 1998-05-13 | Pentapharm A.G. | Positive control plasma for lupus anticoagulant |
| ATE530180T1 (de) | 1997-04-02 | 2011-11-15 | Brigham & Womens Hospital | Verfahren zur ermittlung der individualen risikoprofile atherosklerotischen erkrankungen |
| US6010911A (en) | 1997-04-30 | 2000-01-04 | Medtronic, Inc. | Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique |
| ATE203567T1 (de) | 1998-03-19 | 2001-08-15 | Instrumentation Lab Spa | Verbesserte in vitro verfahren, testkits und reagenzien zum screening von blutgerinnungsfehlern |
-
1999
- 1999-06-30 US US09/345,080 patent/US6502040B2/en not_active Expired - Fee Related
-
2000
- 2000-06-30 KR KR1020017016754A patent/KR20020042539A/ko not_active Withdrawn
- 2000-06-30 WO PCT/US2000/018310 patent/WO2001001152A1/en not_active Ceased
- 2000-06-30 AT AT00947001T patent/ATE328327T1/de not_active IP Right Cessation
- 2000-06-30 CA CA002377528A patent/CA2377528C/en not_active Expired - Lifetime
- 2000-06-30 DE DE60028374T patent/DE60028374T2/de not_active Expired - Lifetime
- 2000-06-30 AU AU60676/00A patent/AU768436B2/en not_active Expired
- 2000-06-30 ES ES00947001T patent/ES2270850T3/es not_active Expired - Lifetime
- 2000-06-30 EP EP00947001A patent/EP1188060B1/en not_active Expired - Lifetime
- 2000-06-30 JP JP2001507105A patent/JP2003529046A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU768436B2 (en) | 2003-12-11 |
| WO2001001152A9 (en) | 2002-05-02 |
| ATE328327T1 (de) | 2006-06-15 |
| EP1188060A4 (en) | 2005-04-13 |
| EP1188060A1 (en) | 2002-03-20 |
| KR20020042539A (ko) | 2002-06-05 |
| CA2377528A1 (en) | 2001-01-04 |
| CA2377528C (en) | 2008-02-05 |
| WO2001001152A1 (en) | 2001-01-04 |
| DE60028374D1 (de) | 2006-07-06 |
| EP1188060B1 (en) | 2006-05-31 |
| AU6067600A (en) | 2001-01-31 |
| JP2003529046A (ja) | 2003-09-30 |
| ES2270850T3 (es) | 2007-04-16 |
| US20020010553A1 (en) | 2002-01-24 |
| US6502040B2 (en) | 2002-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69615556T2 (de) | Verfahren und apparat zum vorhersagen der präsenz von angeborenen und erworbenen unausgewogenheiten und therapeutischen zuständen | |
| DE60026287T2 (de) | Nmr-verfahren zur bestimmung des risikos zur entwicklung von diabetes type 2 | |
| Andrews et al. | Predicting recovery in patients suffering from traumatic brain injury by using admission variables and physiological data: a comparison between decision tree analysis and logistic regression | |
| DE69021849T2 (de) | Verfahren zur Bestimmung des Spiegels von exogenen und endogenen Gerinnungsfaktoren und von Protein C. | |
| Greenland et al. | Control of confounding in the assessment of medical technology | |
| DE60015726T2 (de) | Verfahren und vorrichtung zum vorhersagen von haemostatischer funktionsstörung in patientenproben | |
| DE69737099T2 (de) | Hilfsvorrichtung zur erstellung des befundes bei akutem myokard-infarkt | |
| Canipe III et al. | Diversity of the gut-microbiome related to cognitive behavioral outcomes in healthy older adults | |
| DE60028374T2 (de) | Verfahren und apparatur zum präsentieren von daten von thrombose- und haemostaseassays | |
| DE69633681T2 (de) | Verfahren zur feststellung von reperfusion nach thrombolytischer therapie | |
| DE10341193A1 (de) | Vorrichtung und Verfahren zur quantitativen Auswertung der in einer Körperflüssigkeitsprobe enthaltenden Polypeptide sowie Marker zur Erkennung von pathologischen Zuständen | |
| Peña et al. | Evaluation of the i-STAT point-of-care capillary whole blood prothrombin time and international normalized ratio: comparison to the Tcoag MDAII coagulation analyzer in the central laboratory | |
| Vyshedskiy et al. | Change of transmitter release kinetics during facilitation revealed by prolonged test pulses at the inhibitor of the crayfish opener muscle | |
| Mirus et al. | Effects of pneumatic tube systems on viscoelastic coagulation tests in septic patients and healthy individuals: protocol of the randomized controlled VETaPT-trial | |
| Jones et al. | Assessing outcome measures of oral anticoagulation management in children | |
| DE2812988A1 (de) | Verfahren und anordnung zur erfassung der beta-thalassaemie minor | |
| EP4384802B1 (de) | Verfahren zur erstellung einer datenbank zur ermittlung eines lichttransmissionsaggregometrie-referenzwerts und verfahren und vorrichtung zur durchführung einer lichttransmissionsaggregometrie-messung | |
| House et al. | Predictive validity of Graduate Record Examination scores and undergraduate grades for length of time to completion of degree | |
| Short et al. | Using structural equations to estimate effects of behavioral interventions | |
| Liszka-Hackzell et al. | Analysis of the information content in Sonoclot data and reconstruction of coagulation test variables | |
| AU2004201011B2 (en) | Method and apparatus for presenting thrombosis and hemostasis assay data | |
| DE69906865T2 (de) | Automatisches Diagnosesystem zur Durchführung von Immunoassays und klinisch-chemischen Assays nach einem Reflexalgorithmus | |
| US20060064028A1 (en) | Method for drawing up data which can be used to assess cognitive or sensomotor capabilities or capacities of people subjected to a test | |
| EP0979997A1 (de) | Verfahren und Vorrichtung zum Identifizieren einer von einem Lebewesen abgesonderten Flüssigkeit, insbesondere von Fruchtwasser | |
| Spannagl et al. | POCT in coagulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |